Northwestern Medicine and Vitestro Collaborate to Advance Autonomous Robotic Phlebotomy
Collaboration to Address Global Staffing Shortages and Set a New Standard for Automated Diagnostic Blood Collection CHICAGO and SAN FRANCISCO,...
Clinical Trial
Indero Marks 40th Study Live with Veeva RTSM
Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelines PLEASANTON, Calif., March 19, 2025 /PRNewswire/ --...
Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat...
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with...
HealthTree Foundation Launches Leif, the HealthTree AI Assistant
New AI-Powered Support Assistant Helps Blood Cancer Patients Find Answers and Resources Faster SALT LAKE CITY, March 18, 2025 /PRNewswire/...
DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company’s Prestigious Annual List of the World’s Most Innovative Companies of 2025
NEW YORK, March 18, 2025 /PRNewswire/ -- DarwinHealth is proud to have been named to Fast Company's prestigious list of the...
ClinCapture Unveils New eTMF and Enhanced Subject Audit Log Export Features
LAS VEGAS, March 18, 2025 /PRNewswire/ -- ClinCapture, a leader in clinical trial management solutions, is excited to announce the...
Canopy and Texas Oncology Announce Multi-Year Partnership to Improve Patient Outcomes
NEW YORK, March 18, 2025 /PRNewswire/ -- Canopy, the first Continuous Care Platform for oncology, today announced a multi-year partnership with...
ALZpath Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
Proprietary ALZpath pTau217 Antibody, Utilized in Many of the Most Advanced and Widely Available Blood Tests, Enables Early Diagnosis of Alzheimer's...
Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein
Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapiesNew York, New York--(Newsfile Corp. - March 18,...
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a...
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain
-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first globally to be granted rights...
Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain
Opioid-free and addiction-free pain treatment therapy could address $1.5B worldwide CINP marketATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics,...
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025
WAYNE, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and...
March 2025 Letter to Shareholders
VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year...
Clario announces acquisition of imaging provider NeuroRx
Acquisition further builds on Clario's neuroscience expertise and capabilities PHILADELPHIA, March 17, 2025 /PRNewswire/ -- Clario, a leading provider of...
Springbok Analytics Leads MRI Innovations in Multi-Site Pediatric FSHD Clinical Study
AI-Driven Muscle Analysis to Support MOVE Peds Study, Advancing Trial Readiness for Pediatric FSHD CHARLOTTESVILLE, Va., March 17, 2025 /PRNewswire/...
IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
CAMBRIDGE, United Kingdom, March 17, 2025 /PRNewswire/ -- IgniteData has announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) and Cambridge University Hospitals...
Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
Calgary, Alberta--(Newsfile Corp. - March 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an...
PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer
Press release PEP-Therapy receives FDA Orphan Drug Designation for PEP-010for treatment of Pancreatic Cancer Paris (France), March 17, 2025 –...